New hope for advanced colon cancer patients out of options
NCT ID NCT07491159
Summary
This study tests whether combining three different types of cancer drugs can help people with advanced colorectal cancer that has stopped responding to standard treatments. Researchers will give patients a targeted therapy, an immunotherapy, and an oral chemotherapy together or in sequence. The goal is to see if this combination can shrink tumors, extend survival, and provide a new option for patients who currently have very few choices.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tianjin Cancer Hospital
Tianjin, Tianjin Municipality, 300202, China
Conditions
Explore the condition pages connected to this study.